Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2000
10/24/2000US6138077 Method, apparatus and computer program product for determining a set of non-hybridizing oligonucleotides
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136841 Complexes; medical diagnosis
10/24/2000US6136293 Gas or air filled microbubble suspensions in aqueous phases usable as imaging contrast agents in ultrasonic echography
10/24/2000US6136292 Functional imaging of a human or non-human animal body, which method comprises administering into the gastrointestinal tract a first contrast agent comprising a physiologically tolerable manganese compound or a salt thereof, together with a second
10/19/2000WO2000061197A1 Assessment of gastric emptying disorders
10/19/2000WO2000061194A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000WO2000061191A2 Heat stable coated colloidal iron oxides
10/19/2000WO2000061132A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000040082B1 Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents
10/19/2000WO2000024429A3 Compound
10/19/2000DE19917713A1 Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik Short-chain peptide-dye conjugates as contrast agents for optical diagnostics
10/19/2000CA2382628A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft
10/19/2000CA2369484A1 Assessment of gastric emptying disorders
10/19/2000CA2368490A1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/18/2000EP1045026A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
10/18/2000EP1044692A1 Process and device for dry application of products to inhalable powdery supports
10/18/2000EP1044212A1 Human fk506 binding proteins
10/18/2000EP1043975A1 Magnetically responsive composition
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1270563A Sol-gel coated polarization vessels
10/17/2000US6133736 Transverse relaxation-optimized spectroscopy (=TROSY)
10/17/2000US6133259 Diagnosis of alzheimer's disease
10/17/2000US6132764 Targeted polymerized liposome diagnostic and treatment agents
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132699 Microencapsulated fluorinated gases for use as imaging agents
10/12/2000WO2000059547A2 Method of detecting endometriosis
10/12/2000WO2000023594A9 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP)
10/12/2000DE19914101C1 Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik Perfluoralkylamide, their preparation and their use in the diagnosis
10/12/2000CA2366774A1 Method of detecting endometriosis
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042004A1 Method for tissue perfusion
10/11/2000EP1041999A1 Thrombogenic polypeptide chimeras and conjugates having activity dependent upon association with tumor vascular endothelium
10/11/2000EP1041967A1 Microparticles and their therapeutic or diagnostic use
10/11/2000EP0625068B1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them
10/10/2000US6130204 Peptides
10/10/2000US6129914 Bispecific antibody effective to treat B-cell lymphoma and cell line
10/10/2000US6128918 Containers for hyperpolarized gases and associated methods
10/10/2000CA2030516C Parathyroid hypertensive factor
10/10/2000CA2002839C Parvovirus capsids
10/05/2000WO2000057923A2 Radioactive seed with multiple markers and method for using same
10/05/2000WO2000020625A9 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
10/04/2000EP1040825A1 Means for diagnosing bladder carcinoma
10/04/2000EP1040200A1 Virulence-associated nucleic acid sequences and uses thereof
10/04/2000EP1040168A1 Novel dye-polysaccharide-conjugates and the utilization thereof as a diagnostic
10/04/2000EP1040122A1 Protein binding polypeptides
10/04/2000EP1039929A1 Activated t-cells and their uses
10/04/2000EP1039834A1 Optoacoustic contrast agents and methods for their use
10/04/2000CN1269015A Overhauser magnetic resonance imaging (ORMI) method comprising ex vivo polarization of a magnetic resonance (MR) imaging agent
10/03/2000US6128524 A medicine including a mixture of an infra red fluorescent agent and a photosensitive agent both remain in a diseased part in a depth of an eye fundus for clogging blood vessels by laser beam radiation to bring a photochemical change
10/03/2000US6127529 Metal-chelating 2,6-disubstituted pyridine compounds and their use
10/03/2000US6126946 Hepatocyte-selective oil-in-water emulsion
10/03/2000US6126918 Screening assays to identify therapeutic agents for amyloidosis
10/03/2000US6126916 Radiometal-binding peptide analogues
10/03/2000US6125654 Providing solid xenon with nuclear spin relaxant, loading and positioning the xenon in low temperature refrigerator with surrounding magnetic field enabling high xenon spin polarizations, separating from relaxant
09/2000
09/28/2000WO2000056770A1 ANTI-p53 ANTIBODIES
09/28/2000WO2000056723A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/28/2000WO2000056370A1 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2362703A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/28/2000CA2353556A1 Methods for inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms
09/27/2000EP1038535A2 Use of selected perfluorocarbons for the preparation of diagnostic ultrasound contrast agents
09/27/2000EP1037673A1 Charged lipids and uses for the same
09/27/2000EP1037672A1 Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof
09/27/2000EP1037671A1 Polyrotaxanes
09/27/2000EP0688224B1 A mutant crp-protein and methods and materials for making and using it
09/27/2000CN1267551A Contrast medium for magnetic resonant imaging examination of abdomen
09/26/2000US6124445 Phosphotriester oligonucleotides, amidities and method of preparation
09/26/2000US6124136 Method of monitoring compliance with methadone treatment program
09/26/2000US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control
09/26/2000US6123923 Optoacoustic contrast agents and methods for their use
09/26/2000US6123922 Resilient deformable microballoons for echographic imaging
09/26/2000US6123921 Bifunctional detection agents having an optical dye linked to an MRI contrast agent
09/26/2000US6123920 Superparamagnetic contrast media coated with starch and polyalkylene oxides
09/26/2000US6123919 Using noble gas isotopes having nuclear spin, preferably xenon-129 and/or helium-3
09/26/2000US6123918 Providing hormone-responsive tissue from larva of hormone-responsive amphibian species wherein male or female of species is identified by coloration, contacting tissue with sample, observing indicia of hormonal activity
09/26/2000US6123915 Targeting an imaging agent to bone marrow comprising the step of administering a reagent comprising said imaging agent conjugated to an antibody that specifically binds to cellular adhesion molecules
09/26/2000CA1341102C Tetra-aza macrocycles and metal complexes thereof
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000054816A1 Method for the identification and removal of nits from hair
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000035493A3 Method for localizing a site of disease
09/21/2000WO2000035490A3 Contrast agent for facilitating ocular identification and inspection of lymph nodes
09/21/2000WO2000025819A9 Enhanced radiation therapy
09/21/2000WO2000021560A9 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
09/21/2000WO2000021505A3 Composition for the parenteral administration of active agents
09/21/2000WO2000020042A3 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers
09/21/2000CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2360888A1 Method for the identification and removal of nits from hair
09/20/2000EP1036339A4 Sol-gel coated polarization vessels
09/20/2000EP1036339A1 Sol-gel coated polarization vessels
09/20/2000EP1036333A1 Skin test for schizophrenia
09/20/2000EP1036057A1 Radio-opaque polymer biomaterials
09/20/2000CN1267232A Process for preparation of vesicles
09/20/2000CN1056505C Radiological imaging method
09/19/2000US6121433 For diagnostic, research and therapeutic use; mimic or modulate proteins, enzymes, nucleic acids and lipids
09/19/2000US6121426 Fibrin binding domain polypeptides and uses and methods of producing same
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 354